Increased ventilation caused by improved diaphragmatic efficiency during aminophylline infusion

Area of Science:

• Physiology
• Pharmacology
• Respiratory Medicine

Background:

• Aminophylline is known to increase ventilation (VE).
• The precise mechanism behind this effect, particularly its impact on respiratory muscles, requires further elucidation.
• Understanding aminophylline's action is crucial for respiratory management.

Purpose of the Study:

• To investigate the mechanism by which aminophylline increases ventilation.
• To determine if the observed increase in VE is due to enhanced diaphragmatic contractility or increased central respiratory drive.
• To examine the dose-dependent effects of aminophylline on respiratory parameters in an animal model.

Main Methods:

• 12 anesthetized spontaneously breathing dogs were infused with progressive doses of aminophylline.
• Ventilation (VE), transdiaphragmatic pressure (Pdi0.1), and phrenic nerve stimulation-induced transdiaphragmatic pressure (Pdi) were measured.
• Plasmatic aminophylline levels were correlated with respiratory measurements.

Main Results:

• Aminophylline infusion led to a dose-dependent increase in VE, ranging from 4.2 to 9.5 L/min.
• Transdiaphragmatic pressure indices (Pdi0.1 and Pdi) significantly increased with rising aminophylline levels across all stimulation frequencies.
• No alterations in respiratory system mechanics were observed, and a strong correlation was found between Pdi, Pdi0.1, and VE.

Conclusions:

• The increase in ventilation induced by aminophylline in this animal model is primarily attributed to improved diaphragmatic contractility.
• Aminophylline enhances respiratory muscle function directly, rather than through increased central nervous system output.
• These findings highlight a peripheral mechanism for aminophylline's ventilatory effects.